Citation Impact
Citing Papers
SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
Bone Morphogenetic Protein (BMP) signaling in development and human diseases
2014 Standout
Clinical Significance of a First Positive Nontuberculous Mycobacteria Culture in Cystic Fibrosis
2014
A systematic review of evidence on the links between patient experience and clinical safety and effectiveness
2013 Standout
Mycobacterium avium and Mycobacterium abscessus complex target distinct cystic fibrosis patient subpopulations
2012
Multilocus sequence typing scheme for the Mycobacterium abscessus complex
2014
A new taxonomy for describing and defining adherence to medications
2012 Standout
Ataluren: First Global Approval
2014
Sputum Biomarkers of Inflammation in Cystic Fibrosis Lung Disease
2007
Prevalence of rhinosinusitis among atypical cystic fibrosis patients
2010
A Comparison of Bayesian Methods for Haplotype Reconstruction from Population Genotype Data
2003 Standout
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
Clinical Significance of Differentiation of Mycobacterium massiliense from Mycobacterium abscessus
2010
Wearable biosensors for healthcare monitoring
2019 Standout
Cystic fibrosis
2016 Standout
Inhaled therapies, azithromycin andMycobacterium abscessusin cystic fibrosis patients
2012
Pulmonary Disease Due to Nontuberculous Mycobacteria
2008
Aspergillus Bronchitis in Cystic Fibrosis
2006
Nontuberculous Mycobacteria in Cystic Fibrosis
2007
The Effectiveness of Mobile-Health Technology-Based Health Behaviour Change or Disease Management Interventions for Health Care Consumers: A Systematic Review
2013 Standout
Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection
2010
Predicting the Functional Effect of Amino Acid Substitutions and Indels
2012 Standout
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis
2015
Fungal—bacterial interactions: a mixed bag of mingling microbes
2006
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis
2006
THP-1 cell line: An in vitro cell model for immune modulation approach
2014 Standout
Disruption of the cystic fibrosis transmembrane conductance regulator gene in embryonic stem cells by gene targeting
1992 StandoutNobel
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
New pharmacological approaches for cystic fibrosis: Promises, progress, pitfalls
2014
Selective stalling of human translation through small-molecule engagement of the ribosome nascent chain
2017 StandoutNobel
The Epidemiology of Pancreatitis and Pancreatic Cancer
2013 Standout
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
Reduced risk of nontuberculous mycobacteria in cystic fibrosis adults receiving long-term azithromycin
2015
A new era in the treatment of cystic fibrosis: correction of the underlying CFTR defect
2013
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
2015
Factors Associated with Lung Function Decline in Patients with Non-Tuberculous Mycobacterial Pulmonary Disease
2013
The pulmonary collectins, SP-A and SP-D, orchestrate innate immunity in the lung
2002
Mycobacterium abscessus: an emerging rapid‐growing potential pathogen
2006
Illumination of growth, division and secretion by metabolic labeling of the bacterial cell surface
2015 StandoutNobel
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
2015
The Etiology of Acute Recurrent Pancreatitis in Children
2011
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Autophagy modulation as a potential therapeutic target for diverse diseases
2012 Standout
Interaction Between Primary Alveolar Macrophages and Primary Alveolar Type II Cells Under Basal Conditions and After Lipopolysaccharide Or Quartz Exposure
2006
Azithromycin Reduces Exaggerated Cytokine Production by M1 Alveolar Macrophages in Cystic Fibrosis
2009
Epidemiology of nontuberculous mycobacteria (NTM) amongst individuals with cystic fibrosis (CF)
2016
Non‐tuberculous mycobacteria in children with cystic fibrosis: Isolation, prevalence, and predictors
2009
Nontuberculous mycobacteria
2013
Therapeutic suppression of premature termination codons: Mechanisms and clinical considerations (Review)
2014
Risk factors for Mycobacterium abscessus infection in cystic fibrosis patients; a case–control study
2012
Update on Key Emerging Challenges in Cystic Fibrosis
2014 Standout
End-to-end design of wearable sensors
2022 Standout
Knowledge translation of research findings
2012 Standout
A consensus document for the selection of lung transplant candidates: 2014—An update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation
2014 Standout
Nanosilver: A nanoproduct in medical application
2007 Standout
Cystic fibrosis transmembrane conductance regulator protein repair as a therapeutic strategy in cystic fibrosis
2010
Cystic fibrosis
2009
Toll-like receptors and innate immunity
2001 Standout
Correction of Nonsense BMPR2 and SMAD9 Mutations by Ataluren in Pulmonary Arterial Hypertension
2013
Recognition of Bacterial Endotoxin in the Lungs
2000
Epidemiology of Nontuberculous Mycobacterial Infections and Associated Chronic Macrolide Use among Persons with Cystic Fibrosis
2013
Synthetic Aminoglycosides Efficiently Suppress Cystic Fibrosis Transmembrane Conductance Regulator Nonsense Mutations and Are Enhanced by Ivacaftor
2013
Collectins and Pulmonary Host Defense
1998
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Surfactant protein A and surfactant protein D in health and disease
1998
Immune Protection of Human Milk
1998
Antimicrobial Susceptibility Testing, Drug Resistance Mechanisms, and Therapy of Infections with Nontuberculous Mycobacteria
2012
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
2020 Standout
Cigarette smoke and CFTR: implications in the pathogenesis of COPD
2013
Autonomous sweat extraction and analysis applied to cystic fibrosis and glucose monitoring using a fully integrated wearable platform
2017
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Lab-on-Skin: A Review of Flexible and Stretchable Electronics for Wearable Health Monitoring
2017 Standout
Multicenter Study of Prevalence of Nontuberculous Mycobacteria in Patients with Cystic Fibrosis in France
2009
Interventions for enhancing medication adherence
2014 Standout
Exosomes with Immune Modulatory Features Are Present in Human Breast Milk
2007 Standout
Antimicrobial photodynamic therapy – what we know and what we don’t
2018 Standout
Collectins and collectin receptors in innate immunity
2000
The International Workshop on Meibomian Gland Dysfunction: Report of the Subcommittee on Management and Treatment of Meibomian Gland Dysfunction
2011 Standout
Critique of trials in allergic bronchopulmonary aspergillosis and fungal allergy
2006
A Common Dominant TLR5 Stop Codon Polymorphism Abolishes Flagellin Signaling and Is Associated with Susceptibility to Legionnaires' Disease
2003 StandoutNobel
A systematic dissection of determinants and consequences of snoRNA-guided pseudouridylation of human mRNA
2022 StandoutNobel
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
Clinical Practice Guideline (Update): Adult Sinusitis
2015 Standout
The Peptidoglycan of Mycobacterium abscessus Is Predominantly Cross-Linked by l , d -Transpeptidases
2010
Ataluren as an Agent for Therapeutic Nonsense Suppression
2012
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Community-Associated Methicillin-ResistantStaphylococcus aureus: Epidemiology and Clinical Consequences of an Emerging Epidemic
2010 Standout
Classification Algorithm for Subspecies Identification within the Mycobacterium abscessus Species, Based on Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry
2014
Innate Immune Recognition
2002 Standout
Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains
2010
Medication Adherence Measures: An Overview
2015 Standout
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Lung Infections Associated with Cystic Fibrosis
2002 Standout
Inaccuracy of Single-Target Sequencing for Discriminating Species of the Mycobacterium abscessus Group
2009
Cystic fibrosis–adapted Pseudomonas aeruginosa quorum sensing lasR mutants cause hyperinflammatory responses
2015
Detection of Rapidly Growing Mycobacteria in Routine Cultures of Samples from Patients with Cystic Fibrosis
2011
Antimicrobial Resistance in ESKAPE Pathogens
2020 Standout
Interaction of Surfactant Protein A with Lipopolysaccharide and Regulation of Inflammatory Cytokines in the THP-1 Monocytic Cell Line
2000
Oxidative damage of SP-D abolishes control of eosinophil extracellular DNA trap formation
2018 StandoutNobel
Works of H. Blau being referenced
Studies on Human Milk Macrophages: Effect of Activation on Phagocytosis and Secretion of Prostaglandin E2 and Lysozyme
1983
Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis
2011
Cystic Fibrosis Mutations with Widely Variable Phenotype: The D1152H Example
2006
The significance of sweat Cl/Na ratio in patients with borderline sweat test
1995
Systemic inflammatory mediators and cystic fibrosis genotype
2004
Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy
2005
PTC124 treatment over 3 months improves pharmacodynamic and clinical parameters in patients with nonsense-mutation-mediated CF
2008
Interaction of surfactant protein A with bacterial lipopolysaccharide may affect some biological functions
1995
Reaching the diagnosis of cystic fibrosis--the limits of the spectrum.
2000
Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel
2008